Probiotics Market

The global Probiotics market size is estimated to be valued at USD 71.2 billion in 2024 and is projected to reach USD 105.7 billion by 2029, recording a CAGR of 8.2% in terms of value. The surging demand for probiotics stems from a confluence of factors. Heightened health awareness fosters interest in preventive measures, with probiotics perceived as a natural approach to gut health. Additionally, the growing prevalence of digestive disorders and concerns over antibiotic resistance propel the market. The functional food trend and mounting scientific evidence on the potential benefits of probiotics for various health conditions further fuel consumer interest.

Key players operating in this market include Probi (Sweden), Nestlé (Switzerland), ADM (US), Danone (France), International Flavors & Fragrances Inc. (US), Yakult Honsha Co., Ltd. (Japan), BioGaia (Sweden), MORINAGA MILK INDUSTRY CO., LTD. (Japan), Meiji Holdings Co., Ltd. (Japan), Lifeway Foods, Inc. (US), Adisseo (France), Winclove Probiotics (US), AB-Biotics, S.A. (Belgium), Apsen Farmacêutica (Brazil), and Lallemand (Canada).

To know about the assumptions considered for the study download the pdf brochure

The probiotics market operates within a dynamic framework, continually adapting to evolving scientific insights and shifting consumer preferences. Established strains like Lactobacillus and Bifidobacterium traditionally lead the market, yet the emergence of Proteus strains introduces a new dimension of complexity. Ongoing research endeavors aim to elucidate the potential benefits and safety profiles associated with Proteus strains, contributing to a deeper understanding of their role in probiotic formulations. Regulatory authorities face the challenge of formulating clear guidelines to govern the inclusion of Proteus strains in probiotic products, navigating the complexities of safety and efficacy assessments to ensure consumer welfare and market integrity.

Meanwhile, consumer awareness is on the rise, driven by the functional food trend and marketing efforts. This fosters a demand for diverse probiotic options, potentially creating a niche for Proteus products if their efficacy is demonstrably proven. However, competition within the market is fierce, with established players constantly innovating. Proteus-based probiotics must navigate this competitive landscape while ensuring clear communication about their unique value proposition to health-conscious consumers. Overall, the probiotic market surrounding Proteus is poised for significant development, with the coming years likely to reveal its true potential within this ever-evolving space.

Probi is a global player that research, manufactures, and delivers probiotics for dietary supplements and functional food. The company mainly operates in three geographical regions, including EMEA, the Asia Pacific, and the Americas. The company conducts research and develops products primarily in the field of gastrointestinal health, immune system, metabolic syndrome, and stress & performance recovery. The company offers a range of delivery formats, including capsules, tablets, chewable tablets, spheres, fast melt sticks, and powder for dietary supplement applications. For the food & beverage category, Probi’s products are used in several segments, including chilled beverages, chilled dairy products, chilled plant-based products, frozen desserts, powder formulas, and confectionery. The company has 2 business segments, namely, Goods and Royalties. It offers probiotics through the Goods subsegment under the food & beverage and dietary supplements category. Probi caters to more than 40 markets worldwide and holds over 400 patents. It has expanded its presence in global markets, such as Asia, Europe, and South America, through the acquisition of Nutraceutix (US) in 2016.

A recent noteworthy development in March 2023, Probi announced a strategic partnership with Clasado Biosciences, a leader in prebiotic research, to develop synbiotic products. The collaboration aims to merge Probi's probiotic expertise with Clasado's renowned prebiotic Bimuno GOS, capitalizing on synergistic health benefits. With an initial focus on advancing understanding and future commercialization, this venture signifies Probi's commitment to innovation in the dynamic probiotics market.

Nestlé, a leading global food and beverage conglomerate, boasts a diverse product line encompassing milk and dairy products, beverages, chocolates, confectionery, coffees, creamers, food seasonings, and pet foods. With a portfolio exceeding 2,000 brands, Nestlé serves a broad consumer base, organized into seven key business segments: Powdered and Liquid Beverages, Milk Products and Ice Creams, Nutrition and Health Science, Prepared Dishes and Cooking Aids, Confectionery, Water, and Pet Care.

Under its Nutrition and Health Science segment, Nestlé offers probiotic products. Distinguished by the largest R&D network among food companies worldwide, Nestlé operates 23 R&D facilities, including three science and research centers, and 31 product technology and R&D centers across the globe. This extensive infrastructure supports Nestlé's global presence and innovation efforts. Nestlé operates globally through its 418 factories located in 86 countries worldwide. It has a presence in the Americas, Europe, Asia, Oceania, and Africa. The company distributes its products in over 186 countries through its subsidiaries, such as Gerber Products Company (US), Nestlé Purina Petcare (US), and Nestlé UK Ltd. (UK).

International Flavors & Fragrances Inc. (IFF) is a global multinational corporation that provides a range of products such as animal health solutions, animal feed enzymes, antimicrobials, antioxidants, extracts and flavorings, carob protein, cellulose gum, and cultures for plant-based food. The company is active across various industries, such as animal nutrition, antimicrobial fabric protection, biorefinery, brewing, dietary supplements, fabric & home care, food & beverage, hygiene, and odor control. The company has four business segments, namely, Nourish, Health & Biosciences, Scent, and Pharma Solutions. It provides its extensive range of probiotics through the Health & Biosciences segment under the dietary supplements category, which are targeted towards providing a range of multifunctional health benefits in humans, such as boosting women’s health, immune health, digestive health, weight management, oral health, and brain health.

The company is active across all the major geographical regions, namely, North America, Europe, Asia Pacific, South America, Africa, and the Middle East. The company has dedicated state-of-the-art office and research facilities to reinforce the company’s strong focus on quality control and delivering value-added products, which has enabled the company to become one of the key market leaders in this industry. Some of its prominent subsidiaries are Frutarom Industries Ltd. (Israel), Solae LLC (US), Genencor (US), Butamax Advanced Biofuels LLC (US), Tastepoint Inc. (US), and Sonarome Private Limited (India).

Related Reports:

Probiotics Market by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel and Region - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]